Vincent T. DeVita
Direktor/Vorstandsmitglied bei My Gene Counsel LLC
Profil
Vincent T.
DeVita, Jr. has been Chairman of the Yale Cancer Center Advisory Board since July 2003 and the Amy and Joseph Perella Professor of Medicine at the Yale Cancer Center since 2004.
He has been a Director of CuraGen Corp.
since 1995 and ImClone Systems, Inc. since February 1992.
Dr. DeVita is Chairman of the Advisory Board for Cancersourse.com LLC.
He is Professor of Epidemiology and Public Health at the Yale University School of Medicine in New Haven, Connecticut.
From 1993 to June 2003, Dr. DeVita was a Director of the Yale University Comprehensive Cancer Center.
From September 1988 to June 1993, he served as Physician-in-Chief of the Memorial Sloane-Kettering Cancer Center.
From 1980 to 1988, Dr. DeVita served as Director of the National Cancer Institute.
He received a BS from the College of William and Mary and an MD from the George Washington University School of Medicine in 1961.
Aktive Positionen von Vincent T. DeVita
| Unternehmen | Position | Beginn |
|---|---|---|
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01.01.2004 |
My Gene Counsel LLC
 My Gene Counsel LLC Packaged SoftwareTechnology Services My Gene Counsel LLC operates as a digital health company that develops digital tools and information for genetic test results. The digital information is created and updated by certified genetic counselors, physicians and consumer advocates. It serves laboratories, patients, and health professionals. The company was founded by Ellen Matloff and David Cohen and is headquartered in North Haven, CT. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Vincent T. DeVita
| Unternehmen | Position | Ende |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Direktor/Vorstandsmitglied | 01.10.2009 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Direktor/Vorstandsmitglied | 01.01.1988 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Direktor/Vorstandsmitglied | - |
Ausbildung von Vincent T. DeVita
| George Washington University | Doctorate Degree |
| The College of William & Mary | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Yale Cancer Center
Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Health Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
My Gene Counsel LLC
My Gene Counsel LLC Packaged SoftwareTechnology Services My Gene Counsel LLC operates as a digital health company that develops digital tools and information for genetic test results. The digital information is created and updated by certified genetic counselors, physicians and consumer advocates. It serves laboratories, patients, and health professionals. The company was founded by Ellen Matloff and David Cohen and is headquartered in North Haven, CT. | Technology Services |